These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2956848)

  • 1. On passivation and stenosis: restenosis in coronary artery disease and percutaneous transluminal coronary angioplasty.
    Vogel JH
    Am J Cardiol; 1987 Jul; 60(3):68B-69B. PubMed ID: 2956848
    [No Abstract]   [Full Text] [Related]  

  • 2. [Repeat percutaneous transluminal angioplasty in coronary artery restenosis].
    Ekha IaE; Serka TT; Sulling TA; Rebane TKh; Lukha OA
    Kardiologiia; 1986 Jul; 26(7):31-4. PubMed ID: 2945028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design considerations in the study of restenosis after percutaneous transluminal coronary angioplasty.
    Weintraub WS
    Am J Cardiol; 1987 Jul; 60(3):3B-4B. PubMed ID: 2956838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on percutaneous transluminal coronary angioplasty.
    Cabin HS; Cleman MW
    Cardiol Clin; 1988 Aug; 6(3):321-8. PubMed ID: 2977570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous transluminal coronary angioplasty restenosis: potential prevention with laser balloon angioplasty.
    Spears JR
    Am J Cardiol; 1987 Jul; 60(3):61B-64B. PubMed ID: 2956846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the methodology of percutaneous transluminal coronary angioplasty on restenosis.
    Douglas JS; King SB; Roubin GS
    Am J Cardiol; 1987 Jul; 60(3):29B-33B. PubMed ID: 2956837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features.
    Cox JL; Gotlieb AI
    CMAJ; 1986 May; 134(10):1129-32. PubMed ID: 2938706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiographic morphology of restenosis after percutaneous transluminal coronary angioplasty.
    MacDonald RG; Barbieri E; Feldman RL; Pepine CJ
    Am J Cardiol; 1987 Jul; 60(1):50-4. PubMed ID: 2955692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute left main coronary stenosis: an unusual but serious complication of percutaneous transluminal coronary angioplasty.
    Slack JD; Pinkerton CA
    Angiology; 1985 Feb; 36(2):130-6. PubMed ID: 3161432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic follow-up after multivessel percutaneous transluminal coronary angioplasty.
    Finci L; Meier B; De Bruyne B; Steffenino G; Divernois J; Rutishauser W
    Am J Cardiol; 1987 Sep; 60(7):467-70. PubMed ID: 2957906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat balloon coronary angioplasty for symptomatic restenosis: a note of caution.
    Sugrue DD; Vlietstra RE; Hammes LN; Holmes DR
    Eur Heart J; 1987 Jul; 8(7):697-701. PubMed ID: 2958279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intimal hyperplasia as a cause of restenosis after percutaneous transluminal coronary angioplasty.
    Giraldo AA; Esposo OM; Meis JM
    Arch Pathol Lab Med; 1985 Feb; 109(2):173-5. PubMed ID: 3156573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restenosis and accelerated left main coronary artery disease presenting six months after successful percutaneous transluminal coronary angioplasty.
    Mishkel GJ; Marquis JF
    Can J Cardiol; 1989 May; 5(4):187-90. PubMed ID: 2525065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors, time course and treatment effect for restenosis after successful percutaneous transluminal coronary angioplasty of chronic total occlusion.
    Ellis SG; Shaw RE; Gershony G; Thomas R; Roubin GS; Douglas JS; Topol EJ; Startzer SH; Myler RK; King SB
    Am J Cardiol; 1989 Apr; 63(13):897-901. PubMed ID: 2522727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Restenosis after percutaneous transluminal angioplasty: I. Etiology and clinical significance].
    Alfke H; Böger RH; Bode-Böger SM
    Vasa; 1996; 25(1):13-20. PubMed ID: 8851261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience.
    Guiteras Val P; Bourassa MG; David PR; Bonan R; Crépeau J; Dyrda I; Lespérance J
    Am J Cardiol; 1987 Jul; 60(3):50B-55B. PubMed ID: 2956844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restenosis after multilesion percutaneous transluminal coronary angioplasty.
    Vandormael MG; Deligonul U; Kern MJ; Kennedy H; Galan K; Chaitman B
    Am J Cardiol; 1987 Jul; 60(3):44B-47B. PubMed ID: 2956841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty.
    Whitworth HB; Roubin GS; Hollman J; Meier B; Leimgruber PP; Douglas JS; King SB; Gruentzig AR
    J Am Coll Cardiol; 1986 Dec; 8(6):1271-6. PubMed ID: 2946740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A symposium: restenosis after percutaneous transluminal coronary angioplasty. June 7, 1986, Atlanta, Georgia. Proceedings.
    Am J Cardiol; 1987 Jul; 60(3):1B-69B. PubMed ID: 2956833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.